Page 1 of Clinical Trials for ChemGenex Pharmaceuticals [SPONSOR-COLLABORATORS], 5 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Pharmacokinetic (PK) Study of Homoharringtonine (Omacetaxine Mepesuccinate) Administered Subcutaneously to Patients With Advanced Solid and Hematologic Tumors
Last Updated: May 3, 2012
Condition(s): Hematologic Tumors
2
Completed
Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)
Last Updated: May 16, 2012
Condition(s): Myeloid Leukemia, Chronic; Myeloid Leukemia, Chronic, Accelerated-Phase; Blast Phase; Myeloid Leukemia, Chronic, Chronic-Phase
3
Active, not recruiting
Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene Mutation
Last Updated: May 3, 2012
Condition(s): Chronic Myeloid Leukemia
4
Active, not recruiting
Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CML
Last Updated: May 3, 2012
Condition(s): Chronic Myeloid Leukemia
5
Recruiting
Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)
Last Updated: December 19, 2011
Condition(s): Leukemia

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=ChemGenex+Pharmaceuticals

Page 1 of Clinical Trials for ChemGenex Pharmaceuticals [SPONSOR-COLLABORATORS], 5 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About